FR2352832B1 - - Google Patents

Info

Publication number
FR2352832B1
FR2352832B1 FR7716182A FR7716182A FR2352832B1 FR 2352832 B1 FR2352832 B1 FR 2352832B1 FR 7716182 A FR7716182 A FR 7716182A FR 7716182 A FR7716182 A FR 7716182A FR 2352832 B1 FR2352832 B1 FR 2352832B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7716182A
Other versions
FR2352832A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo NV filed Critical Akzo NV
Publication of FR2352832A1 publication Critical patent/FR2352832A1/fr
Application granted granted Critical
Publication of FR2352832B1 publication Critical patent/FR2352832B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7716182A 1976-05-28 1977-05-26 Nouveaux 17b-esters de testosterone et de 5a-dihydrotestosterone utiles comme androgenes a administration orale Granted FR2352832A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (2)

Publication Number Publication Date
FR2352832A1 FR2352832A1 (fr) 1977-12-23
FR2352832B1 true FR2352832B1 (fr) 1980-07-11

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7716182A Granted FR2352832A1 (fr) 1976-05-28 1977-05-26 Nouveaux 17b-esters de testosterone et de 5a-dihydrotestosterone utiles comme androgenes a administration orale

Country Status (12)

Country Link
JP (1) JPS52148060A (fr)
AR (1) AR214323A1 (fr)
BE (1) BE855163A (fr)
CH (1) CH627761A5 (fr)
DE (1) DE2723876C2 (fr)
DK (1) DK146096C (fr)
ES (1) ES459230A1 (fr)
FI (1) FI57597C (fr)
FR (1) FR2352832A1 (fr)
GB (1) GB1567515A (fr)
NL (1) NL7705790A (fr)
SE (1) SE425493B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0113376A (pt) * 2000-08-23 2003-07-15 Akzo Nobel Nv Uso de um éster de testosterona, método de tratamento de distúrbios de insuficiência de androgênio, e, sistema de liberação de droga para contracepção masculina
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
DE2723876C2 (de) 1986-10-30
FI57597C (fi) 1980-09-10
DK146096C (da) 1983-11-21
DE2723876A1 (de) 1977-12-15
GB1567515A (en) 1980-05-14
BE855163A (fr) 1977-11-28
FI57597B (fi) 1980-05-30
DK236877A (da) 1977-11-29
FI771684A (fr) 1977-11-29
SE7706235L (sv) 1977-11-29
FR2352832A1 (fr) 1977-12-23
JPS6145637B2 (fr) 1986-10-08
JPS52148060A (en) 1977-12-08
SE425493B (sv) 1982-10-04
AR214323A1 (es) 1979-05-31
NL7705790A (nl) 1977-11-30
ES459230A1 (es) 1978-11-16
DK146096B (da) 1983-06-27
CH627761A5 (en) 1982-01-29

Similar Documents

Publication Publication Date Title
US4077328B1 (fr)
FR2345671B3 (fr)
FR2347556B1 (fr)
FR2352832B1 (fr)
JPS5339639B2 (fr)
JPS5319427U (fr)
JPS5340633U (fr)
JPS5294622U (fr)
JPS52170058U (fr)
JPS54349B2 (fr)
JPS52153485U (fr)
JPS52134999U (fr)
JPS5323034U (fr)
JPS52134811U (fr)
JPS5330974U (fr)
JPS52171756U (fr)
CS175346B1 (fr)
CS176995B1 (fr)
CS178377B1 (fr)
DD123820A1 (fr)
CH610432A5 (fr)
DD124034A1 (fr)
DD123878A5 (fr)
DD124334A1 (fr)
DD123785A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse